Next Steps in #CancerHealthEquity: Are You Ready to Engage the Medicaid Population?
Cancer health equity requires reimagining our health care system to focus on reducing patient risk of dying from serious disease due to late-stage diagnosis and/or poor access to high-quality care.
When the Clinical Treatment Act takes effect in January 2022, state Medicaid programs will be required to cover routine care costs for clinical trial participation.
Learn how engaging the Medicaid population in clinical trials and other initiatives can help advance cancer health equity and improve patient outcomes for everyone.
Our panelists will discuss:
The Clinical Treatment Act, and its promise for improving cancer outcomes
NMQF initiatives, including Stage Shifting by advancing Multi-cancer Early Detection Technologies and the new Alliance for Representative Clinical Trials
The activities of NMQF's Diverse Cancer Communities Working Group and ways to get involved
Considerations and opportunities for engaging the Medicaid population in cancer clinical research
This webinar will focus on what you need to know in 2022 to expand your reach to include Medicaid populations in your initiatives for cancer screening, diagnosis, and cancer clinical trials.
Panelists:
Gary Puckrein, PhD
President and Chief Executive Officer
National Minority Quality Forum
Tammy Boyd, JD, MPH
Director of Health Policy and Legislative Affairs
Black Women's Health Imperative
Moderator:
Mary Stober Murray, MPH
Vice President, Collaborative Action Networks
National Minority Quality Forum
Event Details
December 3, 2021 at 12:00pm EST - 1:00pm EST
Please submit questions to Keiko Purnell at kpurnell@nmqf.org. We also welcome suggestions for future webinar topics, as we plan to host more very soon!
